In July 2016, the Colombian government enacted Law 1787, which regulates the use of medicinal cannabis and its trade in the country. With this decision and a series of subsequent resolutions, Colombia joined the more than a dozen countries that have put into practice different types of regulation to explore the advantages of this plant as an alternative pharmaceutical.
Even though, in 1998, the Home Office granted GW Pharmaceuticals a license to grow cannabis in order to develop cannabinoid-based medicines, Britain is not following suit. Norman Baker, Lib Dem minister of state for crime prevention, called for more liberalised drug laws, and specifically the legalisation of cannabis grown for medicinal use. A coalition spokesman rejected his suggestion outright. And so those seeking cannabis for medicinal purposes must continue to chase it in the same way as recreational users, through the black market.
The UK's drug laws are preventing scientists from carrying out vital research to unlock our understanding of the brain and find new treatments for conditions such as depression and Parkinson's disease, according to Professor David Nutt, a leading neuroscientist and former government drug adviser. "Things are actually getting worse," said Nutt, referring to the restrictions placed on research.
Under pressure from the Lib Dems, the Home Office commissioned a report looking at the international evidence on the impact of legislation on drug use. Theresa May, the home secretary, made no secret of the fact that she had no enthusiasm for the project, and when it was published in October, with Baker taking the lead in publicising it, Conservative ministers signalled that they would ignore it. Baker revealed that the original draft had contained policy recommendations that, on May’s orders, had been removed prior to publication.
Liberalised drug laws should be introduced to legalise the widespread use of cannabis to relieve symptoms of certain medical conditions, including the side effects of chemotherapy, the drugs minister Norman Baker will say. Amid concerns that "credible people" are having to break the law to secure the only substance that can help to relieve their condition, Baker is writing to the health secretary, Jeremy Hunt, to call for a review of the medicinal properties of cannabis.
The vaping trend seemingly knows no bounds as the first “cannabis” e-cigarette goes on sale in the UK. The KanaVape, which contains hemp, has been legalised for use in France by people with cancer, multiple sclerosis (MS) and other conditions requiring pain relief. It will go on sale around the world tomorrow but the Home Office has cast doubt on whether that would be legal, saying the product must be tested for controlled substances. KanaVape cannot be compared to a joint because it does not contain THC, the chemical causing cannabis highs.
La légalisation du cannabis en Maroc à des fins thérapeutiques et industrielles permettra les familles de vivre dignement. Après le Parti de l’Istiqlal, le PAM s’apprête à déposer lui aussi une proposition de loi en ce mois de février après avoir terminé ses consultations avec les agriculteurs. Le sujet en tout cas n’est plus tabou, et les parlementaires eux-mêmes, au-delà des calculs électoralistes et politiques que peut revêtir leur initiative, demandent à juste titre un cadre législatif pour son exploitation à des fins médicales et industrielles.
Agriculture Minister Akram Chehayeb called for the legalization of cannabis farming in Lebanon to allow the state to benefit from the revenue of its export. “We are conducting studies on [how to] organize this type of agriculture so that it becomes monitored by the state, and thus the state can buy the harvest and export it to the countries that need it,” Chehayeb said. He added that the state should end its war on cannabis farmers and find workable alternatives.
Eliseu Labigalini Jr, Lucio Ribeiro Rodrigues, Dartiu Xavier Da Silveira
01 October 1999
This study ensued from clinical observations based on spontaneous accounts by crack abusers undergoing their first psychiatric assessment, where they reported using cannabis in an attempt to ease their own withdrawal symptoms.
Pien Metaal, who follows Latin American drug law reform ... told The Tico Times ... that legalizing medical marijuana in Costa Rica “would clearly send a message that can spark a debate in the region... Of course, the debate should not just be about medicinal use,” Metaal wrote, “since in fact recreational use is the largest actually existing phenomena, [for] which simple possession and use are being criminalized and prosecuted.”
Vera da Ros (Rede Brasileira de Redução de Danos e Direitos Humanos - REDUC)
17 July 2014
The IV Symposium on Medicinal Cannabis in Brazil focused on patients who need treatment via medicinal cannabis and its components. Today, these patients struggle with access to such treatment, mainly due to bureaucracy. The event undoubtedly generated attitudes in favor of medical marijuana in the country. However, and unfortunately, less than 10 days after the event ended, National Health Surveillance Agency (ANVISA) postponed a vote for the reclassification of cannabis.
More than 10,000 patients who have official government permission consume marijuana in Israel, a number that has swelled dramatically, up from serving just a few hundred patients in 2005. The medical cannabis industry is expanding as well, fuelled by Israel’s strong research sector in medicine and technology – and notably, by government encouragement. Unlike in the United States and much of Europe, the issue inspires almost no controversy among the government and the country’s leadership.
Executive Chairman of Medicanja, Dr Henry Lowe, is urging a spirit of cooperation between government ministries and agencies involved in the development of Jamaica's ganja industry, following the passage of the Decriminalisation Bill.
Half a century ago, Hebrew University Prof. Raphael Mechoulam isolated and synthesized THC, the main psychoactive compound in the cannabis plant. By 1963, Mechoulam and his research partners had revealed the structure of cannabidiol (CBD), a key ingredient in cannabis. By the following year they had isolated THC for the first time, established its structure and synthesized it.
Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value. Ever since, an increasing number of countries have shown discomfort with the treaty regime’s strictures through soft defections, stretching its legal flexibility to sometimes questionable limits.
In a decision that could have immediate fallout for medical marijuana dispensaries, a state appeals court has ruled that California law allows cities and counties to ban the stores. The contentious issue has bounced through the state courts for years, but the opinion issued Wednesday is the first published one that directly tackles it and does so in unambiguous language. The decision could embolden more cities and counties to enact their own. It also could spur those that have bans to be more aggressive about seeking court orders to close defiant dispensaries.
The nation's top medical organization released a major series of papers on medical cannabis last week in the Journal of the American Medical Association, in a move that constitutes a small step for the AMA, but a giant leap in cannabis medical history.
The 43-year-old war on drugs had never seen such a barrage of opposition as it did in 2014, with successful marijuana legalization initiatives in several U.S. states, California’s historic approval of sentencing reform for low level drug offenders and world leaders calling for the legal regulation of all drugs — all of which cement the mainstream appeal of drug policy alternatives and offer unprecedented momentum going into 2015.